VitalBeam radiotherapy platform receives FDA 510(k) and EU CE mark approval- Varian

Varian has received 510(k) clearance from the FDA, as well as EU CE Mark approval for the VitalBeam radiotherapy platform. VitalBeam uses many of the technologies in the TrueBeam radiosurgery system to enhance precision, safety, and speed of treatment. VitalBeam will be available in a basic package with an 80-leaf collimator for intensity-modulated radiation therapy (IMRT), low-dose megavoltage (MV) imaging using the accelerator beam for image guidance and respiratory gating for motion management. Clinics can add RapidArc radiotherapy for faster IMRT, higher dose delivery rates, an on-board kV X-ray system capable of cone-beam CT imaging, and a higher-resolution 120-leaf collimator. All VitalBeam configurations offer up to three photon and six electron energy levels for flexibility in treatment.